All ADHD medications

Canada · information only

Atomoxetine shortages

Includes Strattera and generics.

Last checked: October 18, 2026. We check once a day.

Next step

Talk to your pharmacist

Your pharmacist can tell you what they have in stock and whether another maker or strength is available. Talk to your prescriber before any change to your medication.

14 reports. Each one covers a single product from one company. Other makers or strengths may still be available.

APO-ATOMOXETINE 25MG

Reported shortage
Form
capsule
Company
APOTEX INC
DIN
02318040
Started
October 13, 2026
Expected end
December 4, 2026 (company estimate)
Reason given
Disruption of the manufacture of the drug.
Report updated
October 16, 2026
View the official report

APO-ATOMOXETINE 40MG

Reported shortage
Form
capsule
Company
APOTEX INC
DIN
02318059
Started
June 30, 2026
Expected end
July 31, 2026 (this estimate has passed and the company hasn't updated it yet)
Reason given
Disruption of the manufacture of the drug.
Report updated
July 30, 2026
View the official report

APO-ATOMOXETINE 60MG

Reported shortage
Form
capsule
Company
APOTEX INC
DIN
02318067
Started
May 19, 2026
Expected end
June 12, 2026 (this estimate has passed and the company hasn't updated it yet)
Reason given
Disruption of the manufacture of the drug.
Report updated
June 4, 2026
View the official report

JAMP ATOMOXETINE 100MG

Reported shortage
Form
capsule
Company
JAMP PHARMA CORPORATION
DIN
02506874
Started
March 12, 2026
Expected end
December 31, 2026 (company estimate)
Reason given
Disruption of the manufacture of the drug.
Report updated
April 22, 2026
View the official report

JAMP ATOMOXETINE 18MG

Reported shortage
Form
capsule
Company
JAMP PHARMA CORPORATION
DIN
02506815
Started
March 12, 2026
Expected end
December 31, 2026 (company estimate)
Reason given
Disruption of the manufacture of the drug.
Report updated
March 28, 2026
View the official report

JAMP ATOMOXETINE 80MG

Reported shortage
Form
capsule
Company
JAMP PHARMA CORPORATION
DIN
02506866
Started
March 12, 2026
Expected end
December 31, 2026 (company estimate)
Reason given
Disruption of the manufacture of the drug.
Report updated
March 28, 2026
View the official report

PMS-ATOMOXETINE 25MG

Reported shortage
Form
capsule
Company
PHARMASCIENCE INC
DIN
02381044
Started
September 15, 2025
Expected end
Not given yet
Reason given
Disruption of the manufacture of the drug.
Report updated
September 16, 2025 (not updated in over a year, so ask your pharmacist whether it still applies)
View the official report

PMS-ATOMOXETINE 40MG

Reported shortage
Form
capsule
Company
PHARMASCIENCE INC
DIN
02381052
Started
September 15, 2025
Expected end
Not given yet
Reason given
Disruption of the manufacture of the drug.
Report updated
October 13, 2026
View the official report

PMS-ATOMOXETINE 60MG

Reported shortage
Form
capsule
Company
PHARMASCIENCE INC
DIN
02381060
Started
September 15, 2025
Expected end
Not given yet
Reason given
Disruption of the manufacture of the drug.
Report updated
September 16, 2025 (not updated in over a year, so ask your pharmacist whether it still applies)
View the official report

RIVA-ATOMOXETINE 25MG

Reported shortage
Form
capsule
Company
LABORATOIRE RIVA INC.
DIN
02405989
Expected to start
June 13, 2025
Expected end
Not given yet
Reason given
Delay in shipping of the drug.
Report updated
June 16, 2026
View the official report

RIVA-ATOMOXETINE 40MG

Reported shortage
Form
capsule
Company
LABORATOIRE RIVA INC.
DIN
02405997
Started
June 2, 2025
Expected end
Not given yet
Reason given
Demand increase for the drug.
Report updated
June 16, 2026
View the official report

TEVA-ATOMOXETINE 10MG

Reported shortage
Form
capsule
Company
TEVA CANADA LIMITED
DIN
02314541
Started
September 17, 2025
Expected end
Not given yet
Reason given
Disruption of the manufacture of the drug.
Report updated
October 2, 2025 (not updated in over a year, so ask your pharmacist whether it still applies)
View the official report

TEVA-ATOMOXETINE 18MG

Reported shortage
Form
capsule
Company
TEVA CANADA LIMITED
DIN
02314568
Started
April 30, 2026
Expected end
July 31, 2026 (this estimate has passed and the company hasn't updated it yet)
Reason given
Disruption of the manufacture of the drug.
Report updated
July 31, 2026
View the official report

TEVA-ATOMOXETINE 60MG

Reported shortage
Form
capsule
Company
TEVA CANADA LIMITED
DIN
02314592
Started
June 3, 2026
Expected end
July 31, 2026 (this estimate has passed and the company hasn't updated it yet)
Reason given
Disruption of the manufacture of the drug.
Report updated
July 31, 2026
View the official report

Information only, not medical advice. This page summarizes shortage reports that drug companies file with Health Canada on Health Product Shortages Canada. A reported shortage does not always mean your pharmacy is out. Other makers or strengths may be available, and the end dates companies give are estimates that often change. Do not stop, change or ration a medication based on this page. Talk to your pharmacist about availability, and talk to your prescriber before any change to your treatment.

Data last checked: October 18, 2026. Source: Health Product Shortages Canada, Government of Canada. After the Diagnosis is not affiliated with Health Canada.